Treatment for Vascular disease | Superior Results vs. PTA
https://www.bostonscientific.com
AdRanger DCB delivered exceptional outcomes in complex lesions at 2-Years. Ranger DCB demonstrated nearly 90% primary patency rates.
Read News · Request a Dosimetry Demo · Check Products · Referrers
Types: Critical Care, Spinal Cord Stimulation, Varicose Veins, Defibrillators and more